% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 97

Loading Chart...

4 inventors (with patents filed for the assignee):

Ramila Philip (6 out of 20 patents)

Venky Ramakrishna (2 out of 8 patents)

Mark M Ross (2 out of 2 patents)

4. Lorraine Keller (1 out of 2 patents)

6 patents: Sort by Forward Citations

1. 10206990 - Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer (2019-02-19),

2. 9907842 - Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer (2018-03-06),

3. 9624284 - Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer (2017-04-18),

4. 9132178 - Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer (2015-09-15),

5. 7919467 - Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer (2011-04-05),

6. 7083789 - Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer (2006-08-01),

Company Overview

Immunotope, Inc. is a biotechnology company focused on developing innovative cancer immunotherapies. Through their proprietary peptide-based vaccines, Immunotope aims to harness the power of the immune system to target and destroy cancer cells. Their cutting-edge research has the potential to revolutionize cancer treatment and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#8 in Doylestown, PA

#1,623 in Pennsylvania

#44,981 in US

Doylestown, PA, United States of America

Immunotope, Inc.

Forward Citations = 97

4 inventors:

Ramila Philip (6 out of 20 patents)

Venky Ramakrishna (2 out of 8 patents)

Mark M Ross (2 out of 2 patents)

4. Lorraine Keller (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunotope, Inc.. Retrieved from https://idiyas.com/company/immunotope

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]